1997
Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide T
Kosten T, Rosen M, McMahon T, Bridge T, O'malley S, Pearsall R, O'connor P. Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide T. The American Journal Of Drug And Alcohol Abuse 1997, 23: 543-553. PMID: 9366972, DOI: 10.3109/00952999709016894.Peer-Reviewed Original Research
1994
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users
Meandzija B, O'Connor P, Fitzgerald B, Rounsaville B, Kosten T. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug And Alcohol Dependence 1994, 36: 109-113. PMID: 7851277, DOI: 10.1016/0376-8716(94)90092-2.Peer-Reviewed Original ResearchConceptsIntravenous drug usersMethadone maintenance treatmentMethadone maintenance programHIV infectionCocaine useMore cocaine useMaintenance treatmentRisk factorsDrug usersMethadone maintenance treatment groupHuman immunodeficiency virus (HIV) transmissionAfrican AmericansMaintenance treatment groupNon-infected subjectsInjection frequencyHIV-negativeHIV testingDrug injectionStratified analysisTreatment groupsTotal cocaineHIVRisk behaviorsGreater riskInfectionManagement of hospitalized intravenous drug users: Role of the internist
O'Connor P, Samet J, Stein M. Management of hospitalized intravenous drug users: Role of the internist. The American Journal Of Medicine 1994, 96: 551-558. PMID: 8017454, DOI: 10.1016/0002-9343(94)90096-5.Peer-Reviewed Original ResearchConceptsIntravenous drug usersDrug usersHIV statusHospital settingPatient's HIV statusCommon clinical dilemmaHospital discharge planningInpatient hospital settingSignificant clinical challengeCommon behavioral issuesSubstance use problemsDrug withdrawalDischarge planningClinical dilemmaClinical challengeMEDLINE searchMedical problemsInternistsUse problemsBehavioral issuesAppropriate knowledgeRelevant literatureManagementReviewEpidemiology
1992
Human immunodeficiency virus infection in intravenous drug users: A model for primary care
O'Connor P, Molde S, Henry S, Shockcor W, Schottenfeld R. Human immunodeficiency virus infection in intravenous drug users: A model for primary care. The American Journal Of Medicine 1992, 93: 382-386. PMID: 1415300, DOI: 10.1016/0002-9343(92)90166-9.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPrimary careTuberculosis prophylaxisSyphilis treatmentVirus infectionDrug treatmentDrug usersPneumocystis carinii pneumonia prophylaxisHepatitis B vaccinePrimary care clinicsPrimary care servicesT-cell testingEligible patientsPneumonia prophylaxisAntiretroviral therapyB vaccineChart reviewPneumococcal vaccineT helperHIV infectionInfluenza vaccineCare clinicsMethadone maintenancePeptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug Users
Rosen M, Bridge T, O'Malley S, Pearsall H, Martini B, O'Connor P, Brett‐Smith H, Thomas H, Van Dyck C, Woods S, Kosten T. Peptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug Users. American Journal On Addictions 1992, 1: 332-338. DOI: 10.1111/j.1521-0391.1992.tb00359.x.Peer-Reviewed Original ResearchHIV-positive intravenous drug usersDouble-blind crossover studyPeptide T treatmentHIV-positive patientsPeptide TOpen clinical trialIntravenous drug usersVasoactive intestinal peptideAIDS dementiaCrossover studyNeuropsychological improvementAZT treatmentIntestinal peptideClinical trialsDrug usersCognitive impairmentPatientsNeuropsychological functionCognitive functionT treatmentPlaceboThree timesWeeksPotential utilityTreatment